Ousted OpenAI CEO Altman discusses possible return, mulls new AI venture

NEW YORK: Sam Altman, the just ousted CEO of OpenAI, is discussing a possible return to the company behind the ChatGPT bot even as he considers launching a new artificial intelligence (AI) venture, a person briefed on the matter said on Saturday.

A day after the board fired him in a surprise move that rocked the tech world, Altman was talking with OpenAI executives about improving the company’s governance structure while he discusses with some core OpenAI researchers and others loyal to Altman how they could start a new AI company, the person said.

The possibilities of a return or a restart for Altman, seen by many as the face of generative AI, are in flux, said the source, who asked not to be named because the source was not authorized to speak on behalf of the parties involved.

OpenAI and Altman did not reply to requests for comment.

Investors in OpenAI, including its biggest backer Microsoft, are discussing damage control, including possibly pushing the board to restore Altman as CEO, fearing a mass exodus of talent without him, other sources said.

Khosla Ventures, an early backer of OpenAI, wants Altman back at OpenAI but “will back him in whatever he does next,” the fund’s founder Vinod Khosla posted on X on Saturday.

Microsoft declined to comment. It reportedly owns 49% of the company, while other investors and employees control 49%, with 2% owned by OpenAI’s nonprofit parent.

Emotions ran high on Saturday as current and former employees were angered by Altman’s sacking and worried over how an upcoming $86 billion share sale could be affected by the sudden management upheaval.

OpenAI, a nonprofit co-founded by billionaire Elon Musk, launched ChatGPT on Nov. 30 last year, setting off a global sensation over generative AI technology that quickly became the world’s fastest-growing software application. It set off a wave of investments and announcements across industries to use AI to enhance everything from financial services and healthcare to entertainment and media.